SCHEMBL5418912

SCHEMBL5418912

CCCn1nc(CC2CCCCC2)c([N+](=O)[O-])c1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ ALDH1A1 P00352 4/20 0.35
▸ HRH1 P35367 1/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.34
▸ MAPT P10636 3/20 0.33
▸ HTT P42858 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ PDE1A P54750 1/20 0.33
▸ PDE1B Q01064 1/20 0.33
▸ PDE1C Q14123 1/20 0.33
▸ ADORA2A P29274 1/20 0.32
▸ ADORA2B P29275 1/20 0.32
▸ CTSK P43235 1/20 0.32
▸ CCNA2 P20248 1/20 0.31
▸ CDK2 P24941 1/20 0.31
▸ CCNA1 P78396 1/20 0.31
▸ POLB P06746 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5418794 0.91 SMN1; SMN2 (0.36) SMN1; SMN2ALDH1A1HRH1HRH3MAPT
SCHEMBL5414707 0.81 SMN1; SMN2 (0.36) SMN1; SMN2ALDH1A1MAPTADORA2AADORA2B
SCHEMBL5414212 0.74 MAPT (0.46) SMN1; SMN2ALDH1A1MAPTHTTLMNA
SCHEMBL5411916 0.72 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1MAPTHTTLMNA
SCHEMBL5418577 0.71 MAPT (0.55) SMN1; SMN2ALDH1A1MAPTHTTLMNA
SCHEMBL5417394 0.71 ALDH1A1 (0.39) SMN1; SMN2ALDH1A1MAPTHTTPOLB
SCHEMBL1196 0.71 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1MAPTHTTPOLB
SCHEMBL28038421 0.70 SMN1; SMN2 (0.60) SMN1; SMN2ALDH1A1MAPTHTTLMNA
SCHEMBL5422728 0.69 SMN1; SMN2 (0.39) SMN1; SMN2ALDH1A1MAPTHTTLMNA
SCHEMBL5411887 0.69 SMN1; SMN2 (0.49) SMN1; SMN2ALDH1A1MAPTGAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7232816-B2 Substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medical products and processes for preparing them PFIZER, INC. (US) 2007-06-19 — — US disclosed
US-6962912-B2 Substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them WARNER-LAMBERT LLC (US) 2005-11-08 — — US disclosed
US-20050130957-A1 Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medical products and processes for preparing them PFIZER INC. 2005-06-16 — — US disclosed
EP-1248787-B1 NOVEL SUBTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM WARNER LAMBERT CO (US) 2004-10-06 — — EP disclosed
US-20030171364-A1 Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them BURNOUF CATHERINE (FR) 2003-09-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050130957-A1 Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medical products and processes for preparing them ADRA2C, CYP3A5, CYP2C19 SMN1; SMN2 3412/4885ALDH1A1 1668/4885HRH1 56/4885
US-20030171364-A1 Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them CYP3A5, THPO, CYP3A4 SMN1; SMN2 3665/4885ALDH1A1 1481/4885HRH1 116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback